Healthcare provider profile · identity verified

Victor Rodriguez

General Practice · YABUCOA, PR · NPI 1790311181

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	251	87
Famotidine	Famotidine	248	102
Synthroid	Levothyroxine Sodium	222	48
Simvastatin	Simvastatin	213	69
Tizanidine Hcl	Tizanidine Hcl	211	154
Metformin Hcl	Metformin Hcl	202	65
Lisinopril	Lisinopril	197	61
Losartan Potassium	Losartan Potassium	186	62
Dexamethasone	Dexamethasone	182	154
Gabapentin	Gabapentin	175	47
Amlodipine Besylate	Amlodipine Besylate	166	51
Rosuvastatin Calcium	Rosuvastatin Calcium	162	51
Nabumetone	Nabumetone	151	119
Methylprednisolone	Methylprednisolone	125	104
Tamsulosin Hcl	Tamsulosin Hcl	119	36
Clonazepam	Clonazepam	103	24
Levothyroxine Sodium	Levothyroxine Sodium	102	26
Omeprazole	Omeprazole	101	29
Meloxicam	Meloxicam	99	61
Pantoprazole Sodium	Pantoprazole Sodium	92	29
Hydrochlorothiazide	Hydrochlorothiazide	81	27
Metoprolol Succinate	Metoprolol Succinate	77	28
Irbesartan	Irbesartan	71	19
Montelukast Sodium	Montelukast Sodium	66	21
Temazepam	Temazepam	63	14
Alendronate Sodium	Alendronate Sodium	59	21
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	59	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	39
Finasteride	Finasteride	54	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	50
Lantus	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Betamethasone Valerate	Betamethasone Valerate	47	37
Enalapril Maleate	Enalapril Maleate	45	17
Carvedilol	Carvedilol	42	12
Clopidogrel	Clopidogrel Bisulfate	42	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	41	35
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	32
Farxiga	Dapagliflozin Propanediol	34	suppressed
Furosemide	Furosemide	33	15
Doxazosin Mesylate	Doxazosin Mesylate	32	12
Mirtazapine	Mirtazapine	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	11
Meclizine Hcl	Meclizine Hcl	30	18
Atenolol	Atenolol	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Glipizide Er	Glipizide	27	suppressed
Jardiance	Empagliflozin	27	13
Memantine Hcl	Memantine Hcl	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Jentadueto	Linagliptin/Metformin Hcl	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Pentoxifylline	Pentoxifylline	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Baclofen	Baclofen	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Clotrimazole	Clotrimazole	18	17
Colchicine	Colchicine	18	suppressed
Fluconazole	Fluconazole	18	17
Sucralfate	Sucralfate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	13
Glipizide	Glipizide	16	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	16	15
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	14
Synjardy	Empagliflozin/Metformin Hcl	14	suppressed
Azithromycin	Azithromycin	13	13
Chlorthalidone	Chlorthalidone	13	suppressed
Eliquis	Apixaban	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Permethrin	Permethrin	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error